Search | JOV | ARVO Journals

jov

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (5)
Journal of Vision (1)

Article Type

ARVO Annual Meeting Abstract (4)
Article (1)
Clinical and Epidemiologic Research (1)

Topics

Clinical and Epidemiologic Research (1)
Eye Anatomy and Disorders (1)
Retina (1)
Visual Psychophysics and Physiological Optics (1)

Tags

body weight (1)
exudative age-related macular degeneration (1)
inference (1)
lifting (1)
perceptual aftereffect (1)
phase 3 clinical trials (1)
validation studies (1)
vision (1)
visual acuity (1)
weight (force) (1)

Filters

Has Multimedia (1)

Specify Date Range

From: To: Apply

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Article July 2016

Action adaptation during natural unfolding social scenes influences action recognition and inferences made about actor beliefs

PDF

Bruce D. Keefe; Joanna Wincenciak; Tjeerd Jellema; James W. Ward; Nick E. Barraclough
TAGS: body weight, inference, lifting, perceptual aftereffect, weight (force)
Journal of Vision. 2016; 16(9):9. doi: https://doi.org/10.1167/16.9.9

Includes: Multimedia, Supplemental Content

ARVO Annual Meeting Abstract June 2013

Baseline Predictors of improvement in self-reported visual function following treatment with ranibizumab in patients with diabetic macular edema

Rohit Varma; Neil Bressler; Chantal Dolan; Linda Yau; James Ward; Shoshana Colman

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4026. doi:

ARVO Annual Meeting Abstract March 2012

Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Diabetic Macular Edema in the United States

Rohit Varma; Neil M. Bressler; Quon Doan; Paul P. Lee; Ivan J. Suner; Mark Danese; Chantal M. Dolan; Adam Turpcu; James Ward; Jason S. Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5739. doi:

ARVO Annual Meeting Abstract March 2012

The Responsiveness of the National Eye Institute Visual Function Questionniare-25 (NEI VFQ-25) to Visual Acuity Gains in Diabetic Macular Edema Patients

Adam Turpcu; Shoshana Colman; Ivan J. Suner; Neil M. Bressler; Rohit Varma; Paul Lee; Chantal Dolan; James Ward; Linda Yau

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6346. doi:

ARVO Annual Meeting Abstract April 2011

Patients with Neovascular AMD Treated with Ranibizumab Report Improvement in Function and Performing Everyday Activities in the MARINA Study

Rohit Varma; Neil Bressler; Ivan J. Suner; Paul P. Lee; James Ward; Chantal Dolan; Shoshana Colman

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):84. doi:

Clinical and Epidemiologic Research August 2009

Responsiveness of NEI VFQ-25 to Changes in Visual Acuity in Neovascular AMD: Validation Studies from Two Phase 3 Clinical Trials

PDF

Ivan J. Suñer; Gregg T. Kokame; Elaine Yu; James Ward; Chantal Dolan; Neil M. Bressler
TAGS: exudative age-related macular degeneration, phase 3 clinical trials, visual acuity, vision, validation studies
Invest. Ophthalmol. Vis. Sci.. 2009; 50(8):3629-3635. doi: https://doi.org/10.1167/iovs.08-3225

Includes: Supplemental Content

« Previous

Advertisement

Follow @ARVOjov

JOV Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 1534-7362

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept